IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.
about
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?Type I insulin-like growth factor receptor signaling in hematological malignancies.Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination StudiesInsulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells.Insulin Receptor Isoforms in Physiology and Disease: An Updated View.Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer.
P2860
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
IGF-1R inhibition sensitizes b ...... (ATR) inhibitor and cisplatin.
@en
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase
@nl
type
label
IGF-1R inhibition sensitizes b ...... (ATR) inhibitor and cisplatin.
@en
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase
@nl
prefLabel
IGF-1R inhibition sensitizes b ...... (ATR) inhibitor and cisplatin.
@en
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase
@nl
P2093
P2860
P356
P1433
P1476
IGF-1R inhibition sensitizes b ...... (ATR) inhibitor and cisplatin.
@en
P2093
Ciara H O'Flanagan
Fionola M Fogarty
Nuala McCabe
Richard D Kennedy
Sandra O'Shea
P2860
P304
56826-56841
P356
10.18632/ONCOTARGET.10862
P407
P577
2016-07-27T00:00:00Z